Crisis at the EMA - but might Rasi return?
This article was originally published in SRA
Executive Summary
The decision by Guido Rasi to step aside as executive director of the European Medicines Agency, the result of a procedural dispute between the EU authorities and the former head of the Bulgarian medicines agency, Emil Hristov, is a big blow to the agency and comes at a particularly bad time for the European Commission after the recent resignation of the head of its health directorate1,2.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.